Doseology Sciences Inc. announced the appointment of Kareem Baalbaki as interim CEO and CFO, and Jeremy Wright as a director. Baalbaki brings over a decade of experience in operations and supply chain management, notably scaling a Canadian frozen CPG company significantly. Wright, a seasoned CFO with experience on the TSX and Nasdaq, joins to strengthen the company's financial leadership. These changes follow the resignations of the previous CEO and CFO, signaling a strategic leadership shift as Doseology focuses on growth in the oral stimulant pouch market.
Doseology Sciences Inc. leadership changes provide context for readers following the company. For readers following Consumer Staples-sector US stocks on Pluang, here is the market snapshot as of Sep 30, 2026 17:02 WIB: 40 of 51 stocks rose today. Herbalife Nutrition Ltd (HLF) traded at USD 12.58 with a 1-day change of +1.13%. Unilever plc (UL) showed a 1-day change of +1.11% and a typical hold time on Pluang of 111 days.
An analyst at Truist Financial raised Wells Fargo's price target to $95, suggesting a 20.74% upside from its current price. This optimism is driven by expected strong third-quarter earnings of $1.85 per share and $22.34 billion in revenue, surpassing...
Oklo is developing advanced fast-fission reactors to power future data centers and industrial hubs, aiming to lead in carbon-free energy. Piper Sandler reaffirmed an "Overweight" rating on the stock, reflecting confidence in Oklo's growth prospects. ...
Nike is set to release its quarterly earnings on October 1, 2026, with analysts forecasting an EPS of $0.44 and revenue of $11.32 billion, both down from last year. The company's stock has fallen 80% this year, hitting 13-year lows, reflecting a chal...
Lamb Weston is set to report Q3 earnings with analysts forecasting an EPS of $0.59, down from $0.74 last year, and revenue around $1.65 billion, nearly flat compared to the prior year. The company’s "Focus to Win" strategy has generated over $100 mil...
Cal-Maine Foods reported a $58.6 million net loss and a 42% drop in net sales, driven by lower conventional egg prices. An analyst downgraded the stock to Hold with a $70 price target, reflecting a modest 2.85% upside from current levels. Despite cha...
